Mustang Bio MBIO
NASDAQ MBIO
$0.58 +0.01 (+1.96%)
As of: Aug 21, 2026 · 2:30 PM EDT

Mustang Bio (MBIO) Property, Plant & Equipment (Net) (2017 - 2024)

Mustang Bio (MBIO) Property, Plant & Equipment (Net) (2017 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Mustang Bio 3.90 Mn 3.90 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 371,000.00
Dec 31, 2024 371,000.00
Sep 30, 2024 421,000.00
Sep 30, 2024 421,000.00
Jun 30, 2024 472,000.00
Jun 30, 2024 472,000.00
Dec 31, 2023 3.25 Mn
Dec 31, 2023 3.25 Mn
Sep 30, 2017 139,000.00
Sep 30, 2017 139,000.00